Capstone Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1008 |
|
|
2025
Q1 | – | Sell |
-5,301
| Closed | -$3.78M | – | 789 |
|
|
2024
Q4 | $3.78M | Buy |
5,301
+4,343
| +453% | +$3.09M | 0.01% | 207 |
|
|
2024
Q3 | $1.01M | Sell |
958
-312
| -25% | -$328K | ﹤0.01% | 280 |
|
|
2024
Q2 | $1.33M | Sell |
1,270
-233
| -16% | -$245K | ﹤0.01% | 280 |
|
|
2024
Q1 | $1.45M | Buy |
1,503
+1,054
| +235% | +$1.01M | 0.01% | 416 |
|
|
2023
Q4 | $394K | Buy |
+449
| New | +$394K | ﹤0.01% | 595 |
|
|
2023
Q3 | – | Sell |
-565
| Closed | -$406K | – | 1264 |
|
|
2023
Q2 | $406K | Buy |
+565
| New | +$406K | ﹤0.01% | 491 |
|
|
2023
Q1 | – | Sell |
-54
| Closed | -$39K | – | 716 |
|
|
2022
Q4 | $39K | Buy |
54
+6
| +13% | +$4.33K | ﹤0.01% | 618 |
|
|
2022
Q3 | $33K | Buy |
48
+24
| +100% | +$16.5K | ﹤0.01% | 692 |
|
|
2022
Q2 | $14K | Buy |
+24
| New | +$14K | ﹤0.01% | 768 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1114 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1039 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1055 |
|
|
2021
Q2 | – | Sell |
-4,030
| Closed | -$1.91M | – | 959 |
|
|
2021
Q1 | $1.91M | Sell |
4,030
-20,555
| -84% | -$9.73M | 0.01% | 187 |
|
|
2020
Q4 | $11.9M | Buy |
24,585
+15,596
| +174% | +$7.53M | 0.04% | 58 |
|
|
2020
Q3 | $5.03M | Buy |
8,989
+8,725
| +3,305% | +$4.88M | 0.03% | 81 |
|
|
2020
Q2 | $165K | Buy |
+264
| New | +$165K | ﹤0.01% | 267 |
|
|
2020
Q1 | – | Sell |
-14,438
| Closed | -$5.42M | – | 511 |
|
|
2019
Q4 | $5.42M | Sell |
14,438
-11,736
| -45% | -$4.41M | 0.03% | 91 |
|
|
2019
Q3 | $7.26M | Sell |
26,174
-6,512
| -20% | -$1.81M | 0.05% | 48 |
|
|
2019
Q2 | $10.2M | Buy |
32,686
+30,305
| +1,273% | +$9.49M | 0.07% | 56 |
|
|
2019
Q1 | $978K | Buy |
+2,381
| New | +$978K | 0.01% | 171 |
|
|
2018
Q4 | – | Sell |
-1,288
| Closed | -$520K | – | 526 |
|
|
2018
Q3 | $520K | Buy |
+1,288
| New | +$520K | 0.01% | 226 |
|
|
2018
Q1 | – | Sell |
-1,096
| Closed | -$412K | – | 368 |
|
|
2017
Q4 | $412K | Buy |
1,096
+596
| +119% | +$224K | 0.01% | 218 |
|
|
2017
Q3 | $223K | Sell |
500
-400
| -44% | -$178K | 0.01% | 352 |
|
|
2017
Q2 | $442K | Buy |
+900
| New | +$442K | 0.01% | 361 |
|
|
2016
Q3 | – | Sell |
-10,303
| Closed | -$3.6M | – | 768 |
|
|
2016
Q2 | $3.6M | Buy |
+10,303
| New | +$3.6M | 0.07% | 106 |
|
|
2016
Q1 | – | Sell |
-400
| Closed | -$217K | – | 656 |
|
|
2015
Q4 | $217K | Sell |
400
-1,000
| -71% | -$543K | 0.01% | 326 |
|
|
2015
Q3 | $651K | Buy |
+1,400
| New | +$651K | 0.02% | 141 |
|